US 8153675
Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
granted A61PA61P13/12A61P43/00
Quick answer
US patent 8153675 (Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid) held by Theravance, Inc. expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P13/12, A61P43/00, A61P9/00, A61P9/04